Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast vs Ketotifen in Pediatric Asthma
NCT00446056Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2003
- Primary completion
- Jun 2004
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of montelukast in asthma (2 arms), sponsored by Organon & Co. Primary endpoint: Improvement of morning peak expiratory flow at 2 weeks. Started Sep 2003; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00446056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446056.